Bioactive Human and Murine Transforming Growth Factor-beta (TGF-β)
Our Story
Our journey at TGF beta - family began with a visionary idea: the development of a revolutionary nano-antibody drug for the causal treatment of autoimmune diseases such as multiple sclerosis, Crohn's disease and others. At the center of this development work was the recombinant protein TGF beta 1, a key element in modern medical research.
During the research and development process, we discovered that the TGF beta 1 we developed was astonishingly effective - many times more potent than the variants previously available on the market. Our breakthroughs have been reviewed and confirmed by the world's most renowned researchers.
However, what makes our TGF beta 1 special is not only its extraordinary effectiveness, but also the way in which we produce it. Thanks to innovative production methods, we have succeeded in drastically reducing the cost of manufacturing TGF beta 1. This enables us to offer the product at a price that is up to 80% below the current market price.
Our mission is to make breakthrough medical solutions more accessible and affordable for patients worldwide. With our TGF beta 1, we have taken a big step towards this vision to make a lasting difference to people's lives.
Our TGF beta 1
-
Sold outProtein: pro-TGF-beta 1, His-tag
Regular price €1.950,00 EURRegular priceUnit price €1.950,00 / per mg€4.495,00 EURSale price €1.950,00 EURSold out
Applications of TGF Beta 1 in biological research
-
Cell Culture
TGF Beta 1 can be used to regulate and control cells, which is essential for applications in research studies and drug discovery projects.
-
Gene expression
TGF Beta 1 plays an important role in the regulation of gene expression, which is of interest for genomics research.
-
Molecular biology
TGF Beta 1 can be used to regulate genes and other molecules, which is useful for studies on signaling pathways and intracellular communication.
Applications of TGF Beta 1 in medical research
-
Cancer therapy
TGF beta 1 plays a role in the growth and spread of cancer cells and can therefore help in the development of cancer therapies and drugs.
-
Tissue repair
Studies have shown that TGF beta 1 can promote the regeneration of tissues and organs, which is of interest in regenerative medicine.
-
Immunology
TGF beta 1 is an important regulator of the immune system and can help to understand and treat autoimmune diseases and inflammation.
Applications of TGF Beta 1 in pharmaceutical research
-
Drug development
TGF Beta 1 can be used to test and improve the effect of drugs on cells and tissue.
-
Side effects
Studies have shown that TGF Beta 1 is also useful in researching the side effects of drugs.
-
Pharmacokinetics
TGF Beta 1 can be used to study the retention time of drugs in the body.
Team
-
Dr. Reinhold Horlacher - Co-Founder, Inventor, Chief Operations
Welcome to TGF beta UG, where innovation and expertise take center stage. We are proud to introduce Dr. Reinhold Horlacher, our Chief Scientific Officer (CSO). Dr. Horlacher, a graduate of the University of Konstanz with a PhD in Biology, is a driving force behind our scientific progress and innovation.
Since founding our company in 2023, Dr. Horlacher has used his extensive experience and knowledge to inspire and lead our team. With a strong foundation in biotechnology research and development, he has been instrumental in shaping our portfolio of services and products, from contract research to advanced development projects.
Dr. Horlacher is known not only for his scientific contributions, but also for his leadership skills. He has been instrumental in ensuring that our company is recognized as a dynamic and innovative player in the biotechnology industry. His vision and commitment to excellence reflect the values and goals of [your company] and ensure that we remain at the forefront of scientific discovery and development.
We invite you to learn more about Dr. Reinhold Horlacher and our dedicated team as we work together at the frontier of scientific possibilities. -
Dr. Thomas Harder - Co-Founder, Inventor
At the heart of our team is Dr. Thomas Harder, a respected biologist and Oxford Reader, who shapes the quality of our research and development with his extensive expertise and commitment.
Dr. Harder, a graduate of the prestigious University of Bonn and Reader at Oxford University, brings a wealth of experience in biological research. His impressive academic background and extensive knowledge in various areas of biology have made him a leading scientist in his field. His work is not only recognized in academic circles, but also has far-reaching applications in the practical world.
At our facility, Dr. Harder leads a team of dedicated scientists and researchers who are committed to the discovery and development of new scientific knowledge. His leadership is characterized by curiosity, precision and a relentless pursuit of knowledge, which puts [your company] at the forefront of research and development in our field.
We are proud to have Dr. Thomas Harder as part of our team, and we invite you to learn more about his groundbreaking work and contributions that make [your company] a pioneer in biological research. -
Dr. Jörg Fregien - Co-Founder, Entrepreneur
Dr. Jörg Fregien, Managing Director of Life Science Pre-Seed-Fonds and Inkubator GmbH is a key figure in our team. Dr. Fregien combines the medical expertise of an experienced physician with the strategic foresight of an accomplished biotechnology manager.
With his extensive experience in corporate structures, particularly in the field of medical technology, Dr. Fregien has successfully led teams of over 500 employees and demonstrated his skills in founding and developing start-ups. His career reflects a rare combination of deep medical understanding and strong entrepreneurial skills.
In his role as Managing Director at Life Science Inkubator GmbH, Dr. Fregien leads innovative projects and drives the development of new technologies and processes in biotechnology. His commitment to promoting start-ups and his contribution to technology transfer are an essential part of our mission to drive medical progress and break new ground in the treatment and prevention of disease.
Dr. Fregien is not only a leader in his field, but also a source of inspiration for our team. We are proud to have him at the helm of our company and look forward to continuing our success story together. -
Christian Mülder, Investor
We are delighted to introduce Christian Mülder as an integral part of our company. As an experienced investor and visionary entrepreneur, Christian Mülder has contributed significantly to the development and growth of our company. With his profound experience in the financial world and a keen eye for forward-looking business ideas, he is a driving force behind our success.
Christian Mülder is not only active as an investor, but also as a co-founder of Crowdswap, where he has been active since June 2021. His career is characterized by an impressive versatility, ranging from founding and managing Dreamrockz Software, Service und Holding GmbH to significant contributions in various start-ups.
His commitment to smart and sustainable investment strategies is reflected in every aspect of our corporate culture. Christian Mülder's ability to recognize and foster innovative ideas, coupled with his deep understanding of the challenges and opportunities in today's market, make him an invaluable member of our team. We are proud to have him at our side and look forward to continuing our successful collaboration. -
Wolfgang Hennes, Co-Founder, CEO
At the head of our dedicated team is Wolfgang Hennes, our esteemed CEO and recognized expert in the field of Artificial Intelligence (AI).
Mr. Hennes brings an exceptional blend of technical expertise and visionary leadership to our company. His outstanding achievements in AI, Big Data and Business Intelligence have made him a household name in the industry. Mr. Hennes is known for his ability to tackle complex technological challenges and develop innovative solutions that put our products and services at the forefront of the market.
Under his leadership, Tranquil Immune has made significant progress and established itself as a leader in the development of AI-powered healthcare solutions. His vision and commitment to excellence is reflected in every aspect of our work and inspires our team to explore new frontiers in science and technology every day.
We are proud to have Wolfgang Hennes as our CEO and look forward to the continued successes and breakthroughs we will achieve under his leadership.
